TransMedics (TMDX) Reports Q3 Earnings: What Key Metrics Have to Say

TransMedics (TMDX) reported $108.76 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 63.7%. EPS of $0.12 for the same period compares to -$0.12 a year ago.The reported revenue represents a surprise of -4.78% over the Zacks Consensus Estimate of $114.22 million. With the consensus EPS estimate being $0.28, the EPS surprise was -57.14%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to d ...